Page 139 - Multidisipliner Covid 19

Enfeksiyon Hastal›klar› Uzman› Gözünden COVID-19 Hastal›¤› ve Karaci¤er

11. Xu Z, Shi L, Wang Y et al. Pathological findings of COVID-19 associated
with acute respiratory distress syndrome. Lancet Respir Med, 2020.
https://doi.org/10.1016/S2213-2600(20)30076-X
12. Chai X, Hu L, Zhang Y, Han W, Lu Z, Ke A. et al. Specific ACE2 Expres-
sion in Cholangiocytes May Cause Liver Damage After 2019-nCoV
Infection. Biorxiv Preprint 4 February 2020: 2020.2002.2003.931766
https://doi.org/10.1101/2020.02.03.931766
13. Midgley CM, The COVID 19 Investigation Team. First 12 patients with
coronavirus disease 2019 (COVID-19) in the United States. https://
www.medrxiv.org/content/10.1101/2020.03.09.20032896v1 https://
doi.org/10.1101/2020.03.09.20032896.
14. Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, et al.
Compassionate use of remdesivir for patients with severe covid-19.
N Engl J Med 2020, http:// dx.doi.org/10.1056/NEJMoa2007016.
15. Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A trial of lopinavir-
ritonavir in adults hospitalized with severe covid-19. N Engl J Med
2020. http://dx.doi. org/10.1056/NEJMoa 2822001.
16. Hydroxychloroquine. LiverTox: Clinical and research information on
drug-induced liver injury. Bethesda (MD): National Institute of Diabetes
and Digestive and Kidney Diseases; 2012. https://www.ncbi.nlm.nih.
gov/books/NBK548738/
17. Tocilizumab. LiverTox: Clinical and research information on drug-
induced liver injury. Bethesda (MD): National Institute of Diabetes
and Digestive and Kidney Diseases; 2012. https://www.ncbi.nlm.nih.
gov/books/NBK547852/
18. Chen L-F, Mo Y-Q, Jing J, Ma J-D, Zheng D-H, Dai L. Short-course
tocilizumab increases risk of hepatitis B virus reactivation in patients
with rheumatoid arthritis: a prospective clinical observation. Int J
Rheum Dis 2017; 20: 859–69. http://dx.doi.org/10.1111/1756-185X.13010.
19. Centers for Disease Control and Prevention. People who are at higher
risk for severe illness https://www.cdc.gov/coronavirus/2019-ncov/
need-extra-precautions/people-at-higher-risk.html (Accessed on April
01, 2020).
20. Boettler T, Newsome PN, Mondelli MU, Maticic M, Cordero E, Cornberg
M, et al. Care of patients with liver disease during the COVID-19
pandemic: EASL- ESCMID position paper. JHEP Rep 2020;2:100113,
http://dx.doi.org/10.1016/j. jhepr.2020.100113.

138